IDXX — IDEXX Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00
- $41.20bn
- $41.74bn
- $3.66bn
- 96
- 11
- 66
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 428 | 582 | 745 | 679 | 845 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 42.2 | 39.8 | 47 | 60.6 | 67.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -105 | -31.8 | -138 | -274 | -72.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 459 | 648 | 756 | 543 | 907 |
Capital Expenditures | -155 | -108 | -120 | -159 | -134 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -50.3 | -1.5 | -173 | -36.5 | 8.38 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -206 | -109 | -293 | -195 | -125 |
Financing Cash Flow Items | -10.6 | -27.3 | -20.7 | -17.5 | -13.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -286 | -248 | -697 | -371 | -442 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -33.5 | 294 | -239 | -31.9 | 341 |